メインナビゲーションにスキップ 検索にスキップ メインコンテンツにスキップ

Erratum: Naldemedine for Opioid-Induced Constipation in Patients With Cancer: A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial (Journal of Clinical Oncology (2024) DOI: 10.1200/JCO.24.00381)

  • Jun Hamano
  • , Takahiro Higashibata
  • , Takaomi Kessoku
  • , Shinya Kajiura
  • , Mami Hirakawa
  • , Shunsuke Oyamada
  • , Keisuke Ariyoshi
  • , Takeshi Yamada
  • , Yoshiyuki Yamamoto
  • , Yasuyuki Takashima
  • , Kosuke Doki
  • , Masato Homma
  • , Bryan J. Mathis
  • , Tsumugi Jono
  • , Tomoki Ogata
  • , Kosuke Tanaka
  • , Yuki Kasai
  • , Michihiro Iwaki
  • , Akiko Fuyuki
  • , Atsushi Nakajima
  • Ryuji Hayashi, Takayuki Ando, Naoki Izawa, Yuko Kobayashi, Yoshiki Horie, Tatsuya Morita

研究成果: ジャーナルへの寄稿コメント/討論

抄録

The article by Hamano et al entitled "Naldemedine for Opioid-Induced Constipation in Patients With Cancer: A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial"(Journal of Clinical Oncology 10.1200/JCO.24.00381) was published online September 10, 2024, with errors. Typographical errors were present in the PAC-QOL row of Table 2 under the Naldemedine and Placebo groups, which also affected the Difference Between Groups and P Value at Day 14. No effect to the outcomes of the study is present due to these errors. This has been corrected as of March 21, 2025. The authors apologize for the errors.

本文言語英語
ページ(範囲)1615
ページ数1
ジャーナルJournal of Clinical Oncology
43
13
DOI
出版ステータス出版済み - 2025/05/01

UN SDG

この成果は、次の持続可能な開発目標に貢献しています

  1. SDG 3 - すべての人に健康と福祉を
    SDG 3 すべての人に健康と福祉を

ASJC Scopus 主題領域

  • 腫瘍学
  • 癌研究

フィンガープリント

「Erratum: Naldemedine for Opioid-Induced Constipation in Patients With Cancer: A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial (Journal of Clinical Oncology (2024) DOI: 10.1200/JCO.24.00381)」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル